Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05849844 · ClinicalTrials.gov registry record · NA
Tympanoseal Clinical Study
A NA study of Tympanic Membrane Perforation, sponsored by Grace Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 2
- Study locations
NCT05849844 is a NA study of Tympanic Membrane Perforation that is actively recruiting participants, run by Grace Medical. The registered enrollment target is 45 participants, below the 155-participant average among 3 other Tympanic Membrane Perforation trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05849844, a NA study of Tympanic Membrane Perforation, is actively recruiting participants, sponsored by Grace Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this investigational study is to assess the ability of Tympanoseal (sodium/calcium alginate), an investigational device, to act as a scaffold during healing of the tympanic membrane. Tympanoseal is intended for use following removal or extrusion of indwelling tympanostomy tubes or traumatic injury of the tympanic membrane.
Conditions Studied
Interventions
- DEVICE Tympanoseal
Study Locations (2)
Michigan
- Michigan Ear Institute - Farmington Hills
Tennessee
- Methodist Le Bonheur - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2024-01-05 |
| Est. Completion | 2026-04-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05849844
The ClinicalTrials.gov registry entry for NCT05849844 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 155-participant average among 3 other Tympanic Membrane Perforation trials with a reported enrollment target (71% lower). The listed sponsor is Grace Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tympanic Membrane Perforation appearing as the primary indexed condition, and to 1 intervention - of which Tympanoseal is the first listed.
NCT05849844 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Tennessee.
Frequently Asked Questions
What is clinical trial NCT05849844 about?
NCT05849844 is a clinical study titled "Tympanoseal Clinical Study". The purpose of this investigational study is to assess the ability of Tympanoseal (sodium/calcium alginate), an investigational device, to act as a scaffold during healing of the tympanic membrane. Tympanoseal is intended for use following removal or extrusion of indwelling tympanostomy tubes or tra...
What is the current status of trial NCT05849844?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2024-01-05. Estimated completion is 2026-04-20.
What conditions does trial NCT05849844 study?
This clinical trial studies the following conditions: Tympanic Membrane Perforation.
What interventions are being tested in trial NCT05849844?
The interventions under investigation include: Tympanoseal (DEVICE).
Who is sponsoring clinical trial NCT05849844?
This trial is sponsored by Grace Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05849844 being conducted?
This trial has 2 study locations across Michigan, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tympanic Membrane Perforation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.